	Adjuvant pressurized intraperitoneal aerosol chemotherapy (PIPAC) in suboptimally cytoreduced advanced ovarian cancer: a randomized phase II trial (PIPAC-OVA). BMC Cancer Dzasokhov AS, Khomyakov VM, Turiev AV, Astashov VL, Kostin AA, Gunyakov SO, Andreeva MA. PMID: 42243730 [PubMed - as supplied by publisher]
	Risk factors for residual cancer and lymph node metastasis after non-curative endoscopic resection of colorectal cancer: a multicenter retrospective study. BMC Gastroenterol Oh SY, Oh HH, Kim YI, Kim DH, Joo YE, Kim HS, Kang WK, Lee JL, Yoon YS, Kim CW, Park IJ, Lim SB. PMID: 42243702 [PubMed - as supplied by publisher]
	Construction and validation of a machine learning-based prediction model for social isolation in patients with colorectal cancer after stoma surgery. BMC Gastroenterol Zhang W, Qu L. PMID: 42243692 [PubMed - as supplied by publisher]
	Skin cancer mortality in Australian and New Zealand kidney transplant recipients: A population-based cohort study using linked health data, 1990-2019. Br J Dermatol Forcey DS, Rosales BM, Wyld ML, De La Mata N, Khosrotehrani K, Webster AC. PMID: 42243641 [PubMed - as supplied by publisher]
	An interpretable ultrasound-based deep learning system for early breast cancer in a Chinese population. Insights Imaging Wu S, Wang S, Liang D, Shi J, Shang X, Zhang L, Liu Y, Su X, Wang Y, Lu Q, Li Z, Zhao Z, Ji X, Li D, He Y. PMID: 42243600 [PubMed]
	Clinical and Pathological Characteristics and Prognosis of Breast Cancer During Pregnancy and Postpartum: A Multicenter Retrospective Study. Cancer Rep (Hoboken) Wang L, Deng H, Fang X, Li T, Chen Q, Liu J. PMID: 42243585 [PubMed - in process]
	EWSR1::BEND2 gene fusions characterize a majority of ACTH-producing neuroendocrine neoplasms of the pancreas: A follow-up study and brief review of the recent literature. Virchows Arch Agaimy A, Adsay V, Stoehr R, Pavel ME, Lena MS. PMID: 42243580 [PubMed - as supplied by publisher]
	Association of baseline tumor-infiltrating lymphocytes and cell-cycle regulation markers on prognosis and mortality in patients with advanced breast cancer according to tumor characteristics and treatment type: an observational study. Breast Cancer Res Treat Vuoti S, Saari M, Lahti J, Narasimha K, Reinikainen K. PMID: 42243565 [PubMed - in process]
	Post-neoadjuvant and peri-operative ctDNA-defined minimal residual disease in triple-negative breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat Barjij I, Naciri S, Lkhoyaali S, Kharmoum S, Inrhaouen H, Elghissassi I, Boutayeb S, Mrabti H, Errihani H. PMID: 42243561 [PubMed - in process]
	Retrospective study on regional nodal irradiation after omission of axillary lymph node dissection in sentinel lymph node-positive breast cancer: a propensity score matching analysis. Breast Cancer Res Treat Xia K, Tang N, Li D, Wang L, Xiao H. PMID: 42243510 [PubMed - in process]
	Label-free interferometry platform for drug response profiling of bioprinted tumor organoids at single-organoid resolution. Nat Protoc Wang B, Tebon PJ, Nguyen TL, Murray GF, Guest DC, Reed J, Sartini S, Soragni A, Teitell MA. PMID: 42243509 [PubMed - as supplied by publisher]
	Contrast-enhanced MRI improves the diagnostic performance for vaginal fornix invasion in cervical carcinoma. Insights Imaging Yang K, Rong F, Chu F, Dong Y, Zhang H, Wan B, Xu M, Xia Q, Lu L, Song HY, Chen H, Qu J. PMID: 42243469 [PubMed]
	Exposure-safety analyses of talazoparib in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) in the TALAPRO-2 trial. J Pharmacokinet Pharmacodyn Wang Y, Hadigol M, Lincha VR, Hoffman J, Azad AA, Agarwal N, Matsubara N, Zohren F, DeAnnuntis L, Wang DD. PMID: 42243460 [PubMed - in process]
	Comprehensive multi-omics analysis identifies cancer subtypes and prognostic signatures of hepatitis B virus-associated hepatocellular carcinoma. NPJ Precis Oncol Wang R, Ren B, Zhang X, Liu B, Zhou W. PMID: 42243437 [PubMed - as supplied by publisher]
	Development of ultrasonography for the detection of prostate cancer. J Med Ultrason (2001) Kuroda S, Yuzuriha S, Takahashi K, Naruse J, Nakajima N, Shoji S. PMID: 42243380 [PubMed - as supplied by publisher]
	A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasms. Br J Cancer Evans TRJ, Cook N, El-Khoueiry A, Pinato DJ, Tran NH, Hsiehchen D, Mena E, Meyer T, Wu J, Pathak SM, Paoletti C, Dutta L, Okpara CE, Lopez JS. PMID: 42243349 [PubMed - as supplied by publisher]
	Bacterial engineering for cancer therapy. Nat Cancer Chen N, Yang Z, Arpaia N. PMID: 42243277 [PubMed - as supplied by publisher]
	Evaluation of the predictive accuracy of nine staging systems in patients with hepatocellular carcinoma: a multicenter, retrospective study in China. Sci Rep Wang S, Li Y, Leng S, Li C, Zhu H, Lv J, Zheng D, Lin H, Zhong J, Zhao M, Xue J, Huang P, Chen Z, Zhu Q, Fang W, Liu X, Yang Y, Wang N. PMID: 42243153 [PubMed - as supplied by publisher]
	Cancer burden among adults aged 65 years and older in Asia, 1990-2023: a systematic analysis of the Global Burden of Disease Study 2023. NPJ Aging Zhou T, Zhou E, Lu W, Zou J, Zhang J, Li C, Shen H, Xu C, Shen Y, Li J, Zhu H, Xu C, Yi H, Yin S, Huang W. PMID: 42243143 [PubMed - as supplied by publisher]
	Global, regional, and national trends in burden of lung cancer and chronic obstructive pulmonary disease and associated risk factors, 1990-2021: results from the global burden of disease study 2021. NPJ Prim Care Respir Med Qian J, Zhou S, Wang R, Wu Q, Meng J, Zhang J, Zhang Y. PMID: 42243105 [PubMed - as supplied by publisher]

Articles 1 - 20 / 1940707

Page 1 of 97036



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy